These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 29885152

  • 1. Recent Self-Reported Cannabis Use Is Associated With the Biometrics of Delta-9-Tetrahydrocannabinol.
    Smith MJ, Alden EC, Herrold AA, Roberts A, Stern D, Jones J, Barnes A, O'Connor KP, Huestis MA, Breiter HC.
    J Stud Alcohol Drugs; 2018 May; 79(3):441-446. PubMed ID: 29885152
    [Abstract] [Full Text] [Related]

  • 2. Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial.
    Hjorthøj CR, Fohlmann A, Larsen AM, Arendt M, Nordentoft M.
    Addiction; 2012 Jun; 107(6):1123-31. PubMed ID: 22151583
    [Abstract] [Full Text] [Related]

  • 3. Enhanced cannabis timeline followback (EC-TLFB): Comprehensive assessment of cannabis use including standard THC units and validation through biological measures.
    Petrilli K, Lawn W, Lees R, Mokrysz C, Borissova A, Ofori S, Trinci K, Dos Santos R, Leitch H, Soni S, Hines LA, Lorenzetti V, Curran HV, Freeman TP.
    Addiction; 2024 Apr; 119(4):772-783. PubMed ID: 38105033
    [Abstract] [Full Text] [Related]

  • 4. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
    Desrosiers NA, Lee D, Concheiro-Guisan M, Scheidweiler KB, Gorelick DA, Huestis MA.
    Clin Chem; 2014 Feb; 60(2):361-72. PubMed ID: 24185550
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of Cannabis Brownies: A Controlled Examination of Δ9-Tetrahydrocannabinol and Metabolites in Blood and Oral Fluid of Healthy Adult Males and Females.
    Spindle TR, Cone EJ, Herrmann ES, Mitchell JM, Flegel R, LoDico C, Bigelow GE, Vandrey R.
    J Anal Toxicol; 2020 Oct 12; 44(7):661-671. PubMed ID: 32591782
    [Abstract] [Full Text] [Related]

  • 8. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.
    Karschner EL, Swortwood MJ, Hirvonen J, Goodwin RS, Bosker WM, Ramaekers JG, Huestis MA.
    Drug Test Anal; 2016 Jul 12; 8(7):682-9. PubMed ID: 26097154
    [Abstract] [Full Text] [Related]

  • 9. Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.
    Karschner EL, Schwilke EW, Lowe RH, Darwin WD, Herning RI, Cadet JL, Huestis MA.
    J Anal Toxicol; 2009 Oct 12; 33(8):469-77. PubMed ID: 19874654
    [Abstract] [Full Text] [Related]

  • 10. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
    Fabritius M, Chtioui H, Battistella G, Annoni JM, Dao K, Favrat B, Fornari E, Lauer E, Maeder P, Giroud C.
    Anal Bioanal Chem; 2013 Dec 12; 405(30):9791-803. PubMed ID: 24202191
    [Abstract] [Full Text] [Related]

  • 11. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
    Lee D, Milman G, Barnes AJ, Goodwin RS, Hirvonen J, Huestis MA.
    Clin Chem; 2011 Aug 12; 57(8):1127-36. PubMed ID: 21677094
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration.
    Milman G, Schwope DM, Schwilke EW, Darwin WD, Kelly DL, Goodwin RS, Gorelick DA, Huestis MA.
    Clin Chem; 2011 Nov 12; 57(11):1597-606. PubMed ID: 21875944
    [Abstract] [Full Text] [Related]

  • 14. Assessing cannabis consumption frequency: Is the combined use of free and glucuronidated THCCOOH blood levels of diagnostic utility?
    Hädener M, Martin Fabritius M, König S, Giroud C, Weinmann W.
    Drug Test Anal; 2017 Jul 12; 9(7):1043-1051. PubMed ID: 27732768
    [Abstract] [Full Text] [Related]

  • 15. Urinary clearance of 11-nor-9-carboxy-Δ9 -tetrahydrocannabinol: A detailed pharmacokinetic analysis.
    Sempio C, Huestis MA, Kaplan B, Klawitter J, Christians U, Henthorn TK.
    Drug Test Anal; 2022 Aug 12; 14(8):1368-1376. PubMed ID: 35332698
    [Abstract] [Full Text] [Related]

  • 16. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis.
    Desrosiers NA, Himes SK, Scheidweiler KB, Concheiro-Guisan M, Gorelick DA, Huestis MA.
    Clin Chem; 2014 Apr 12; 60(4):631-43. PubMed ID: 24563491
    [Abstract] [Full Text] [Related]

  • 17. Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations.
    Huestis MA, Elsohly M, Nebro W, Barnes A, Gustafson RA, Smith ML.
    Ther Drug Monit; 2006 Aug 12; 28(4):540-4. PubMed ID: 16885722
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence.
    Schuster RM, Potter K, Vandrey R, Hareli M, Gilman J, Schoenfeld D, Evins AE.
    J Psychopharmacol; 2020 Feb 12; 34(2):197-210. PubMed ID: 31535597
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.